Humanes herpesvirus 8 (HHV-8) and Kaposi sarcoma;Humanes herpesvirus 8 (HHV-8) und Kaposi-sarkom

Hautarzt

Volumn 59, Issue 1, 2008, Pages 18-25

  Lebbe C ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Herpesvirus 8 (HHV 8); Immunodeficiency; Kaposi sarcoma; Kaposi sarcoma associated herpesvirus (KSHV); Methods of transmission

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNE STATUS; KAPOSI SARCOMA; SEXUAL TRANSMISSION; TUMOR REGRESSION; VIRUS INFECTION;

ANTINEOPLASTIC AGENTS; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PRECANCEROUS CONDITIONS; SARCOMA, KAPOSI;

EID: 39149102497     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-007-1445-3     Document Type: Article

References (78)

1. Chang Y, Cesarman E, Pessin MS et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266(5192): 1865-1869
2. Schulz TF (2006) The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol 208(2): 187-198
3. Renne R, Lagunoff M, Zhong W, Ganem D (1996) The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 70(11): 8151-8154
4. Orenstein JM, Alkan S, Blauvelt A et al. (1997) Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. Aids 11(5): F35-45
5. Moore PS, Gao SJ, Dominguez G et al. (1996) Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol 70(1): 549-558
6. Neipel F, Albrecht JC, Fleckenstein B (1997) Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J Virol 71(6): 4187-4192
7. Kajumbula H, Wallace RG, Zong JC et al. (2006) Ugandan Kaposi's sarcoma-associated herpesvirus phylogeny: evidence for cross-ethnic transmission of viral subtypes. Intervirology 49(3): 133-143
8. Hayward GS (1999) Human herpesvirus 8 latent-state gene expression and apoptosis in Kaposi's sarcoma lesions. J Natl Cancer Inst 91(20): 1705-1707
9. Nicholas J, Zong JC, Alcendor DJ et al. (1998) Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8. J Natl Cancer Inst Monogr 23: 79-88
10. Blackbourn DJ, Lennette E, Klencke B et al. (2000) The restricted cellular host range of human herpesvirus 8. Aids 14(9): 1123-1133
11. Renne R, Blackbourn D, Whitby D et al. (1998) Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 72(6): 5182-5188
12. Hong YK, Foreman K, Shin JW et al. (2004) Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36(7): 683-685
13. Wang HW, Trotter MW, Lagos D et al. (2004) Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36(7): 687-693
14. Blasig C, Zietz C, Haar B et al. (1997) Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 71(10): 7963-7968
15. Boshoff C, Schulz TF, Kennedy MM et al. (1995) Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1(12): 1274-1278
16. Widmer IC, Erb P, Grob H et al. (2006) Human herpesvirus 8 oral shedding in HIV-infected men with and without Kaposi sarcoma. J Acquir Immune Defic Syndr 42(4): 420-425
17. Barozzi P, Bosco R, Vallerini D et al. (2006) KSHV/HHV-8 infection of tubular epithelial cells in transplantation kidney. Transplantation 82(6): 851-852
18. Akula SM, Naranatt PP, Walia NS et al. (2003) Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J Virol 77(14): 7978-7990
19. Lu C, Gordon GM, Chandran B et al. (2002) Human herpesvirus 8 reactivation and human immunodeficiency virus type 1 gp120. Arch Pathol Lab Med 126(8): 941-946
20. Wang FZ, Akula SM, Pramod NP et al. (2001) Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol 75(16): 7517-7527
21. Kaleeba JA, Berger EA (2006) Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science 311(5769): 1921-1924
22. Veettil MV, Sharma-Walia N, Sadagopan S et al. (2006) RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner. J Virol 80(23): 11432-11446
23. Foreman KE, Friborg J Jr et al. (1997) Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med 336(3): 163-171
24. Lebbe C, de Cremoux P, Rybojad M et al. (1995) Kaposi's sarcoma and new herpesvirus. Lancet 345(8958): 1180
25. Vieira J, O'Hearn P, Kimball L et al. (2001) Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J Virol 75(3): 1378-1386
26. Grundhoff A, Ganem D (2004) Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113(1): 124-136
27. Adams PD (2001) Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim Biophys Acta 1471(3): M123-133
28. Verschuren EW, Jones N, Evan GI (2004) The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin. J Gen Virol 85(Pt 6): 1347-1361
29. Verma SC, Lan K, Robertson E (2007) Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol 312: 101-136
30. Widmer I, Wernli M, Bachmann F et al. (2002) Differential expression of viral Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus and human Bcl-2 in primary effusion lymphoma cells and Kaposi's sarcoma lesions. J Virol 76(5): 2551-2556
31. Djerbi M, Screpanti V, Catrina AI et al. (1999) The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med 190(7): 1025-1032
32. Sturzl M, Hohenadl C, Zietz C et al. (1999) Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 91(20): 1725-1733
33. Moore PS, Chang Y (2003) Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol 57: 609-639
34. Stine JT, Wood C, Hill M et al. (2000) KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood 95(4): 1151-1157
35. Arvanitakis L, Geras-Raaka E, Varma A (1997) Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385(6614): 347-350
36. Cesarman E, Nador RG, Bai F et al. (1996) Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 70(11): 8218-8223
37. Couty JP, Gershengorn MC (2004) Insights into the viral G protein-coupled receptor encoded by human herpesvirus type 8 (HHV-8). Biol Cell 96(5): 349-354
38. Guo HG, Sadowska M, Reid W et al. (2003) Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J Virol 77(4): 2631-2639
39. Coscoy L (2007) Immune evasion by Kaposi's sarcoma-associated herpesvirus. Nat Rev Immunol 7(5): 391-401
40. Coscoy L, Ganem D (2000) Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA 97(14): 8051-8056
41. Coscoy L, Ganem D (2001) A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J Clin Invest 107(12): 1599-1606
42. Mutlu AD, Cavallin LE, Vincent L et al. (2007) In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 11(3): 245-258
43. Sodhi A, Chaisuparat R, Hu J et al. (2006) The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell 10(2): 133-143
44. Matsushima AY, Strauchen JA, Lee G et al. (1999) Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol 23(11): 1393-1400
45. Du MQ, Diss TC, Liu H et al. (2002) KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood 100(9): 3415-3418
46. Luppi M, Barozzi P, Schulz TF et al. (2000) Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med 343(19): 1378-1385
47. Corchero JL, Mar EC, Spira TJ et al. (2001) Comparison of serologic assays for detection of antibodies against human herpesvirus 8. Clin Diagn Lab Immunol 8(5): 913-921
48. Sarmati L (2001) Serological testing for human herpesvirus 8. Herpes 8(3): 76-79
49. Schatz O, Monini P, Bugarini R et al. (2001) Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol 65(1): 123-132
50. Laney AS, Peters JS, Manzi SM et al. (2006) Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection. J Clin Microbiol 44(10): 3734-3741
51. Pellet C, Chevret S, Blum L et al. (2001) Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. J Invest Dermatol 117(4): 858-863
52. Pellet C, Chevret S, Frances C et al. (2002) Prognostic value of quantitative Kaposi sarcoma - associated herpesvirus load in posttransplantation Kaposi sarcoma. J Infect Dis 186(1): 110-113
53. Pellet C, Kerob D, Dupuy A et al. (2006) Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma. J Invest Dermatol 126(3): 621-627
54. Dupin N, Fisher C, Kellam P et al. (1999) Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96(8): 4546-4551
55. Dukers NH, Rezza G (2003) Human herpesvirus 8 epidemiology: what we do and do not know. Aids 17(12): 1717-1730
56. Plancoulaine S, Gessain A (2005) Epidemiological aspects of human herpesvirus 8 infection and of Kaposi's sarcoma. Med Mal Infect 35(5): 314-321
57. Hladik W, Dollard SC, Mermin J et al. (2006) Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 355(13): 1331-1338
58. Moore PS, Chang Y, Jaffe HW (2007) Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 356(1): 88; author reply 89
59. Barozzi P, Luppi M, Facchetti F et al. (2003) Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med 9(5): 554-561
60. Luppi M, Barozzi P, Rasini V et al. (2002) Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. Transplantation 74(1): 131-132
61. Regamey N, Tamm M, Binet I et al. (1999) Transplantation-associated Kaposi's sarcoma: herpesvirus 8 transmission through renal allografts. Transplant Proc 31(1-2): 922-923
62. Plancoulaine S, Abel L, van Beveren M et al. (2000) Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356(9235): 1062-1065
63. Kouri V, Marini A, Nambiar S et al. (2007) Nearly identical strains of human herpesvirus 8 in couples discordant for Kaposi's sarcoma. Aids 21(6): 765-768
64. Engels EA, Pfeiffer RM, Goedert JJ et al. (2006) Trends in cancer risk among people with AIDS in the United States 1980-2002. Aids 20(12): 1645-1654
65. Grabar S, Le Moing V, Goujard C et al. (2005) Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection. J Acquir Immune Defic Syndr 39(3): 284-292
66. Bower M, Nelson M, Young AM et al. (2005) Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 23(22): 5224-5228
67. Frances C, Lebbe C (2005) Kaposi's disease in an organ transplant recipient: should one anticipate, stabilise or try to cure the disease? Ann Dermatol Venereol 132(11 Pt 1): 829-831
68. Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L et al. (2007) Management of AIDS-related Kaposi's sarcoma. Lancet Oncol 8(2): 167-176
69. Krown SE, Lee JY, Lin L et al. (2006) Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. J Acquir Immune Defic Syndr 41(2): 149-153
70. Kedes DH, Ganem D (1997) Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest 99(9): 2082-2086
71. Klass CM, Offermann MK (2005) Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma. Curr Opin Oncol 17(5): 447-455
72. Martin DF, Dunn JP, Davis JL et al. (1999) Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel. Am J Ophthalmol 127(3): 329-339
73. Crum-Cianflone NF, Wallace MR, Looney D (2006) Successful secondary prophylaxis for primary effusion lymphoma with human herpesvirus 8 therapy. Aids 20(11): 1567-1569
74. Curreli F, Friedman-Kien AE, Flore O (2005) Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. J Clin Invest 115(3): 642-652
75. Lebbe C, Euvrard S, Barrou B et al. (2006) Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transplant 6(9): 2164-2168
76. Stallone G, Schena A, Infante B et al. (2005) Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352(13): 1317-1323
77. Guihot A, Dupin N, Marcelin AG et al. (2006) Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J Infect Dis 194(8): 1078-1088
78. Lambert M, Gannage M, Karras A et al. (2006) Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. Blood 108(12): 3871-3880